Current and Future Directions for PARP Inhibition

Megan Grudem, APRN, CNP, and Andrea Wahner Hendrickson, MD, reviewed the potential role of PARP inhibition in various malignancies, how to select patients who are appropriate candidates, and guidance on devising treatment plans that include PARP inhibitors for patients with ovarian or breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Grudem, Megan, Hendrickson, Andrea Wahner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857320/
https://www.ncbi.nlm.nih.gov/pubmed/33598329
http://dx.doi.org/10.6004/jadpro.2020.11.3.16
_version_ 1783646424741707776
author Grudem, Megan
Hendrickson, Andrea Wahner
author_facet Grudem, Megan
Hendrickson, Andrea Wahner
author_sort Grudem, Megan
collection PubMed
description Megan Grudem, APRN, CNP, and Andrea Wahner Hendrickson, MD, reviewed the potential role of PARP inhibition in various malignancies, how to select patients who are appropriate candidates, and guidance on devising treatment plans that include PARP inhibitors for patients with ovarian or breast cancer based on genetic profiles, tolerability, dosing schedules, and other key factors.
format Online
Article
Text
id pubmed-7857320
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-78573202021-02-16 Current and Future Directions for PARP Inhibition Grudem, Megan Hendrickson, Andrea Wahner J Adv Pract Oncol Meeting Reports Megan Grudem, APRN, CNP, and Andrea Wahner Hendrickson, MD, reviewed the potential role of PARP inhibition in various malignancies, how to select patients who are appropriate candidates, and guidance on devising treatment plans that include PARP inhibitors for patients with ovarian or breast cancer based on genetic profiles, tolerability, dosing schedules, and other key factors. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857320/ /pubmed/33598329 http://dx.doi.org/10.6004/jadpro.2020.11.3.16 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Grudem, Megan
Hendrickson, Andrea Wahner
Current and Future Directions for PARP Inhibition
title Current and Future Directions for PARP Inhibition
title_full Current and Future Directions for PARP Inhibition
title_fullStr Current and Future Directions for PARP Inhibition
title_full_unstemmed Current and Future Directions for PARP Inhibition
title_short Current and Future Directions for PARP Inhibition
title_sort current and future directions for parp inhibition
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857320/
https://www.ncbi.nlm.nih.gov/pubmed/33598329
http://dx.doi.org/10.6004/jadpro.2020.11.3.16
work_keys_str_mv AT grudemmegan currentandfuturedirectionsforparpinhibition
AT hendricksonandreawahner currentandfuturedirectionsforparpinhibition

Ejemplares similares